Written by a model from the transcript; not yet reviewed.
This episode explores the history and ongoing controversy surrounding the body mass index, or BMI, and the modern push by some researchers to introduce race-specific cutoffs. The guest, Atlantic staff writer Katie Wu, explains to the host, Regina Barber, that BMI was created in the 1830s by a European scientist to define the ideal white male form rather than serve as a medical diagnostic tool. Despite being a blunt and universal metric that fails to account for individual differences in muscle mass, body shape, and fat distribution, it remains deeply entrenched in clinical practice because it is simple and fast. Wu and Barber discuss the Screen at 23 movement, which emerged after researchers noticed that many Asian Americans were developing type 2 diabetes at much lower BMIs due to a tendency to accumulate dangerous visceral fat around organs. While lowering the cutoff helps catch cases that would otherwise fall through the cracks, it also highlights the tensions of using race as a biological proxy in medicine. The discussion evaluates alternative measurements, such as waist-to-hip ratios or universal blood screening tests like A1C, and concludes that medicine is slowly reckoning with the need to move beyond traditional BMI and race-based categorizations.
The episode opens with a brief sponsor message from iXL before the host introduces the topic of BMI and its medical relevance.
The discussion covers BMI’s 200‑year history, its European origins, and its original intent as a measure of ideal body form rather than a medical tool.
Speakers highlight how BMI fails to account for differences in sex, muscle mass, lifestyle, and racial/ethnic variation, leading to misclassification.
The conversation turns to evidence that certain racial groups, especially Asian Americans, are under‑screened for type 2 diabetes when using standard BMI cutoffs.
They examine data suggesting reduced undiagnosed diabetes in Asian Americans, while noting the lack of systematic evidence and the risk of reinforcing racial categories.
The discussion explores practical alternatives such as waist circumference, body scans, and blood tests, weighing feasibility and accuracy.
Speakers consider universal screening, A1C testing, and other approaches that bypass BMI entirely, debating cost‑effectiveness and equity.
The episode concludes with reflections on how medicine may evolve to use more individualized, non‑race‑based metrics while acknowledging systemic hurdles.
The host wraps up with thanks, a brief recap, and a final sponsor announcement from iXL and EasyCater.
Origins of BMIstory
The metric was invented in the 1830s by a European scientist who wanted to determine the characteristics of the ideal white male form.
Universal Metric Flawsinsight
Applying a universal categorization metric to billions of people with different sexes, heritages, and lifestyles is bound to fail.
Visceral Fat Risksinsight
Certain Asian American subgroups tend to accumulate dangerous visceral fat around organs rather than subcutaneous fat, leading to insulin resistance at lower weights.
Asian Americans were historically underrepresented in national health surveys until 2011, making it hard to track the impact of targeted screening guidelines.
Measurement Difficultiesdebate
Measuring waist and hip circumference introduces practical challenges like where to place the tape measure and how breathing affects the reading.
Universal Blood Testingstrategy
An alternative approach being considered is to stop relying on messy physical screening and instead test everyone above a certain age with A1C blood sugar tests.
“BMI was never intended for medical use.”
“There are people with, you know, quote unquote, high or overweight or obese BMIs who are extremely healthy.”
“And it seems like certain subgroups of Asian Americans tend to carry more of this fat.”
“We need something that can take into account actual fat mass, actual muscle mass, you know, things that actually tell us about body composition and the types of cells in our body that are actually putting us at higher or lower risk of specific diseases.”
“And so there's kind of no escaping this degree to which we do need to personalize for everyone, but also, what's the ceiling on how much we can personalize without, you know, adding hours to the schedules of clinicians who are already so overstretched, especially in primary care?”
BMI is a quick, cheap way for doctors to estimate body fat and screen for conditions like heart disease and diabetes. But medicine has long known that BMI is problematic and unnuanced. By using it, groups of people have fallen through the cracks and conditions have been caught late. So, some doctors want to add nuance – to consider race when using BMI. But using race in medicine comes with its own problems. So what’s the way forward? To find out, we talk to Katie Wu, a science writer at The Atlantic. Read more of Katie’s reporting on BMI and race https://www.theatlantic.com/health/2026/05/bmi-race-sensitive/687054/. Interested in more science health stories? Email us your question at [email protected] mailto:[email protected]. Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org http://plus.npr.org. See pcm.adswizz.com https://pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy https://www.npr.org/about-npr/179878450/privacy-policy
2,827 words · 4 speakers
Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.
Page updated · transcript and summary are machine-generated